Furthermore, taking into account that BCLC‐B is a quite heterogenic group of patients which includes patients with various tumor burden and different liver disease severity,25 we further assessed the diagnostic accuracy of those biomarkers in BCLC‐B patients according to ALBI classification (ALBI‐I vs. ALBI‐II/III). Here, PPIB is linked to liver disorder.